Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05153252 · ClinicalTrials.gov registry record · NA

Timing Intervention of Morning Versus Evening Exercise

A NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT05153252: Recruiting NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.

NCT05153252 is a NA study of Overweight and Obesity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 128 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05153252, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The investigators are doing this study to learn more about how exercising at different times of the day (morning versus evening) affects body weight, sleep, eating patterns, and other factors.

Primary Outcome

Body weight will be measured using a digital scale at baseline, 3.5, 7, and 13 months. The primary outcome will be change in weight from baseline to 7 months.

Conditions Studied

Interventions

  • BEHAVIORAL Morning Exercise
  • BEHAVIORAL Evening Exercise

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2021-12-07
Est. Completion 2027-03-31
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT05153252 shows while recruiting

NCT05153252 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Morning Exercise is the first listed.

NCT05153252 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05153252 about?

NCT05153252 is a clinical study titled "Timing Intervention of Morning Versus Evening Exercise". The investigators are doing this study to learn more about how exercising at different times of the day (morning versus evening) affects body weight, sleep, eating patterns, and other factors.

What is the current status of trial NCT05153252?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2021-12-07. Estimated completion is 2027-03-31.

What conditions does trial NCT05153252 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT05153252?

The interventions under investigation include: Morning Exercise (BEHAVIORAL), Evening Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05153252?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05153252 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05153252's enrollment target sits among peer trials

128 48th of 115 higher than 67 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05153252, the US trial registry maintained by the National Library of Medicine. NCT05153252 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.